CESCA THERAPEUTICS INC. (34)

Browse by Contract Category

Contracts

Supply Agreement between BioHit Healthcare (Hefei) Co., Ltd. and ThermoGenesis Holdings, Inc. dated August 11, 2020 (Filed With SEC on August 14, 2020)
Payment Protection Program Loan (PPP Loan) between ThermoGenesis Holdings, Inc. and Comerica Bank dated April 21, 2020 (Filed With SEC on August 14, 2020)
Fourth Amendment to the ThermoGenesis Holdings, Inc. 2016 Equity Incentive Plan, effective June 4, 2020 (Filed With SEC on June 9, 2020)
Amendment No. 1 to At The Market Offering Agreement, dated May 19, 2020, by and between ThermoGenesis Holdings, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on May 20, 2020)
Joint Venture Agreement, dated as of October 21, 2019, between Cesca Therapeutics Inc. and Healthbanks Biotech (USA) Inc (Filed With SEC on October 22, 2019)
Manufacturing and Supply Amending Agreement #2, effective as of July 13, 2020, between ThermoGenesis Holdings, Inc. and CBR Systems, Inc (Filed With SEC on July 17, 2020)
Form of Stock Option Agreement (Filed With SEC on June 9, 2020)
Supply Agreement, effective as of April 22, 2020, between ThermoGenesis Corp. and ImmuneCyte Life Sciences Inc (Filed With SEC on April 28, 2020)
Engagement Agreement, dated as of March 24, 2020, by and between ThermoGenesis Holdings, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on March 27, 2020)
Form of Securities Purchase Agreement, dated as of March 25, 2020, between ThermoGenesis Holdings, Inc. and the Purchasers identified on the signature pages thereto (Filed With SEC on March 27, 2020)
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 24, 2020)
Manufacturing and Supply Amending Agreement #1, effective as of March 16, 2020, between ThermoGenesis Corp. and CBR Systems, Inc (Filed With SEC on March 20, 2020)
Form of Stock Option Award Agreement (Filed With SEC on January 3, 2020)
Stockholders Agreement, dated November 22, 2019, among ThermoGenesis Holdings, Inc., Healthbanks Biotech (USA) Inc. and ImmuneCyte Life Sciences Inc (Filed With SEC on November 27, 2019)
Contribution Agreement, dated November 22, 2019, between ThermoGenesis Holdings, Inc. and ImmuneCyte Life Sciences Inc (Filed With SEC on November 27, 2019)
Supply Agreement, dated November 22, 2019, between ThermoGenesis Holdings, Inc. and ImmuneCyte Life Sciences Inc (Filed With SEC on November 27, 2019)
Amendment No. 1, dated July 23, 2019, to the Convertible Promissory Note, dated January 29, 2019 between Cesca therapeutics Inc. and Orbrex USA Co (Filed With SEC on November 19, 2019)
Supply Agreement, dated as of August 30, 2019, between Corning Incorporated and Cesca Therapeutics Inc (Filed With SEC on September 6, 2019)
Amendment No. 1 to the Convertible Promissory Note, Dated July 23, 2019 between Cesca therapeutics Inc. and Orbrex USA Co (Filed With SEC on August 13, 2019)
Cesca Therapeutics Inc. Amended 2016 Equity Incentive Plan (Filed With SEC on August 13, 2019)
Amendment No. 1 to the Convertible Note Agreement dated as of July 23, 2019, between Cesca Therapeutics Inc. and Orbrex USA Co (Filed With SEC on July 29, 2019)
Securities Purchase Agreement, dated as of July 23, 2019, between Cesca Therapeutics Inc. and the Purchaser identified on the signature pages thereto (Filed With SEC on July 29, 2019)
Form of Note (Filed With SEC on July 29, 2019)
Third Amendment to Cesca Therapeutics Inc. Amended 2016 Equity Incentive Plan, dated December 14, 2018 (Filed With SEC on June 4, 2019)
Securities Purchase Agreement, dated as of April 18, 2019, between Cesca Therapeutics Inc. and the Purchaser identified on the signature pages thereto (Filed With SEC on April 25, 2019)
Form of Pre-Funded Warrant (Filed With SEC on April 25, 2019)
Voting Agreement between CARTXpress Bio, Inc. and Bay City Capital Fund V, L.P. and Bay City Capital Management V LLC (Filed With SEC on March 26, 2019)
Securities Purchase Agreement, dated as of January 29, 2019, between Cesca Therapeutics Inc. and the Purchasers identified on the signature pages thereto (Filed With SEC on January 31, 2019)
Form of Note (Filed With SEC on January 31, 2019)
Amended and Restated Certificate of Incorporation of CARTXpress Bio, Inc (Filed With SEC on January 4, 2019)
Right of First Refusal and Co-Sale Agreement, dated January 1, 2019, among CARTXpress Bio, Inc., ThermoGenesis Corp., Bay City Capital Fund V, L.P., and Bay City Capital Fund V... (Filed With SEC on January 4, 2019)
Investors Rights Agreement, dated January 1, 2019, among CARTXpress Bio, Inc., Bay City Capital Fund V, L.P., and Bay City Capital Fund V Co-Investment Fund, L.P (Filed With SEC on January 4, 2019)
Voting Agreement, dated January 1, 2019, among CARTXpress Bio, Inc., ThermoGenesis Corp., Bay City Capital Fund V, L.P., and Bay City Capital Fund V Co-Investment Fund, L.P (Filed With SEC on January 4, 2019)
Reorganization and Share Exchange Agreement, dated January 1, 2019, among ThermoGenesis Corp., Cesca Therapeutics Inc., CARTXpress Bio, Inc., Bay City Capital Fund V. L.P. and Bay... (Filed With SEC on January 4, 2019)